We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Not All Adverse Events in Clinical Trials Should Be Reported to IRBs
Not All Adverse Events in Clinical Trials Should Be Reported to IRBs
April 13, 2007
Individual adverse events in clinical trials are not necessarily the same thing as unanticipated problems and may not have to be reported as such to the institutional review board (IRB), according to new draft guidance from the FDA.